Pyxis Oncology (PYXS) Analyst & Key Data

Analyst Consensus

Analyst recommendation mix is not available yet.

Total Analysts7

Ratings

Updated Sep 12, 2026

Overall Rating

C-

DCF Score3.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$3.21

Median Target+118.07%

$7.00

Potential upside vs current price

DCF Value-48.86%

$1.64

Potential downside vs current price

Current Stock Price

$3.21

Median Target+118.07%

$7.00

Potential upside vs current price

DCF Value-48.86%

$1.64

Potential downside vs current price

Analyst Consensus

Analyst recommendation mix is not available yet.

Total Analysts7

Ratings

Updated Sep 12, 2026

Overall Rating

C-

DCF Score3.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$3.21

Median Target+118.07%

$7.00

Potential upside vs current price

DCF Value-48.86%

$1.64

Potential downside vs current price

Current Stock Price

$3.21

Median Target+118.07%

$7.00

Potential upside vs current price

DCF Value-48.86%

$1.64

Potential downside vs current price

Pyxis Oncology, Inc.